ABSTRACT
Objective In 2020, SARS-CoV-2 impacted Georgia, USA. Georgia announced state-wide shelter-in-place on April 2 (implemented the next day) and announced the partial lifting of restrictions on April 27. Time-varying reproduction number estimates might vary depending on methodology.
Methods Daily incidence of confirmed COVID-19 cases by reporting date, March 2-June 14, 2020, in Georgia, Metro Atlanta, and Dougherty County were analyzed. We estimated and compared the COVID-19 time-varying reproduction number, Rt, by R package EpiEstim (with a window of 1 and 2 weeks) and the renewal equation tied to the generalized growth model (GGM).
Results The EpiEstim Rt estimates are more sensitive to fluctuation in incident cases than the GGM estimates. The median EpiEstim Rt estimate (1-week window) in Georgia dropped from between 2 and 4 in mid-March, to <2 in late March and early April. The median Rt dropped <1 for the first time on April 15. Rt fluctuates around 1 from mid-April to June 14. The Rt estimate by GGM dropped below 2 on March 7 and stabilized to the range of 1 to 1.1 by March 31.
Conclusions GGM estimated Rt as an overall trend over a 3-month period, while EpiEstim is sensitive to daily variation in incidence.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
GC acknowledges support from NSF grant 1414374 as part of the joint NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program. ICHF acknowledges salary support from the National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (19IPA1908208). This article is not part of ICHF's CDC-sponsored projects.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Georgia Southern University Institutional Review Board made a nonhuman subjects determination for this project (H20364), under the G8 exemption category.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email addresses: km11200{at}georgiasouthern.edu (K. Muniz-Rodriguez); gchowell{at}gsu.edu (G. Chowell); jschwind{at}georgiasouthern.edu (J. S. Schwind); rf08112{at}georgiasouthern.edu (R. Ford); so01935{at}georgiasouthern.edu (S. K. Ofori); co05814{at}georgiasouthern.edu (C. A. Ogwara); md18742{at}georgiasouthern.edu (M. R. Davies); tj10163{at}georgiasouthern.edu (T. Jacobs); westerpants{at}gmail.com (C.-H. Cheung); lcowan{at}georgiasouthern.edu (L. Cowan); ahansen{at}georgiasouthern.edu (A. Hansen); cfung{at}georgiasouthern.edu (I. C.-H. Fung)
Disclaimer: The opinions expressed in this paper does not necessarily represent the official positions of the CDC or the United States Government.
Data Availability
All data used in the analysis is presented in the Supplementary Materials.